The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hypertension and cardiotoxicity in metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU).
Veronica Prati
No relevant relationships to disclose
Cinzia Ortega
No relevant relationships to disclose
Valentina Ballatore
No relevant relationships to disclose
Danilo Galizia
No relevant relationships to disclose
Fiorella Ruatta
No relevant relationships to disclose
Alessandro Bonzano
No relevant relationships to disclose
Sandra Aliberti
No relevant relationships to disclose
Giovanni Grignani
No relevant relationships to disclose
Massimo Aglietta
No relevant relationships to disclose